270-271 / 1778
• Initiative EMBRACE study group within GEC-ESTRO
• Start inclusion 2016, 1000 patients intended
• Aims for
EBRT and brachytherapy
• Exclusive IMRT
• SIB boosting for lymph node metastases
• Extension elective field based on defined risk profile
• ………………………………….
Ongoing evidence for improving treatment planning